Otipax (Phenazone, Lidocaine Hydrochloride)

Phenazone, the active ingredient in Otipax, is an analgesic and local anesthetic presented as a topical formulation for ear, nose and throat use. It relieves mild pain and discomfort associated with inflammatory conditions of the upper respiratory tract. GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otipax combines phenazone and lidocaine to provide symptomatic relief in the upper respiratory tract. It is commonly used for: - Sore throat: reduces pain and irritation in the pharyngeal mucosa. - Minor ear pain: eases discomfort associated with otitis externa or mild ear canal irritation. - Nasal discomfort: soothes irritation of the nasal mucosa due to colds or allergies. - Post‑procedural throat discomfort: alleviates mild pain after throat examinations or minor procedures.

Side effects are generally mild and localized to the area of application.

Common Side Effects: - Transient burning or stinging sensation at the site of application. - Mild erythema or redness of the mucosa. - Temporary taste alteration. - Minor swelling of the treated area.

Serious or Rare Side Effects: - Allergic contact dermatitis presenting with intense itching, swelling, or rash. - Severe mucosal ulceration or erosion. - Systemic hypersensitivity reactions such as angio‑edema or anaphylaxis. - Persistent numbness extending beyond the application site.

Before using Otipax, consider the following precautions: - Allergy assessment: avoid if known hypersensitivity to phenazone, lidocaine, or excipients. - Application area: limit to mucosal surfaces; do not use on broken skin or open wounds. - Duration of use: do not exceed the period recommended by a healthcare professional. - Concomitant medications: inform the prescriber of other topical anesthetics or analgesics being used. - Pediatric use: safety and efficacy have not been established in children under 12 years. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

interactions:

This   

t   t